Alto Neuroscience (ANRO)
Alto Neuroscience on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on NYSE.
5.2M
Short interest
settlement 2026-10-15
7.5
Days to cover
+1.0 days vs prior
66.8%
Short share of volume
2026-11-02
48
Fails to deliver
settlement 2026-10-14
Wed 11 Nov
Next earnings
estimated date
-$3.6M
Insider flow, 90 days
0 buys, 3 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ANRO is 5,204,407 shares, up 1,030,325 shares over the last month. Over the last 48 readings it ranged from 1,587,188 shares (30 April 2026) to 5,204,407 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 694K shares a day that is 7.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/anro" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 5,204,407 | +11.7% | 694,107 | 7.50 |
| 2026-09-30 | 4,660,269 | +11.7% | 718,187 | 6.49 |
| 2026-09-15 | 4,174,082 | +8.8% | 459,493 | 9.08 |
| 2026-08-31 | 3,836,359 | +7.9% | 475,830 | 8.06 |
| 2026-08-14 | 3,556,066 | +9.9% | 475,999 | 7.47 |
| 2026-07-31 | 3,235,210 | +4.5% | 434,265 | 7.45 |
| 2026-07-15 | 3,096,805 | +28.5% | 719,885 | 4.30 |
| 2026-06-30 | 2,410,038 | +48.6% | 805,527 | 2.99 |
| 2026-06-15 | 1,622,197 | -4.1% | 373,591 | 4.34 |
| 2026-05-29 | 1,692,318 | +5.0% | 305,825 | 5.53 |
| 2026-05-15 | 1,611,876 | +1.6% | 343,534 | 4.69 |
| 2026-04-30 | 1,587,188 | -27.6% | 261,988 | 6.06 |
| 2026-04-15 | 2,190,772 | +6.8% | 407,748 | 5.37 |
| 2026-03-31 | 2,051,993 | +3.4% | 370,037 | 5.55 |
| 2026-03-13 | 1,984,788 | -2.9% | 249,337 | 7.96 |
| 2026-02-27 | 2,043,099 | -4.3% | 195,796 | 10.43 |
| 2026-02-13 | 2,135,475 | -0.0% | 256,031 | 8.34 |
| 2026-01-30 | 2,135,587 | -1.6% | 167,344 | 12.76 |
| 2026-01-15 | 2,171,494 | -1.3% | 205,408 | 10.57 |
| 2025-12-31 | 2,198,907 | -20.9% | 490,970 | 4.48 |
| 2025-12-15 | 2,781,726 | +0.5% | 355,034 | 7.84 |
| 2025-11-28 | 2,767,123 | -1.6% | 350,116 | 7.90 |
| 2025-11-14 | 2,810,725 | -1.3% | 468,648 | 6.00 |
| 2025-10-31 | 2,847,368 | +26.6% | 2,113,498 | 1.35 |
| 2025-10-15 | 2,248,165 | +36.9% | 6,084,518 | 1.00 |
| 2025-09-30 | 1,641,893 | +0.0% | 90,405 | 18.16 |
| 2025-09-15 | 1,641,280 | -3.5% | 66,888 | 24.54 |
| 2025-08-29 | 1,700,751 | -4.6% | 105,514 | 16.12 |
| 2025-08-15 | 1,782,098 | -17.0% | 93,100 | 19.14 |
| 2025-07-31 | 2,147,256 | +4.8% | 127,625 | 16.82 |
| 2025-07-15 | 2,049,775 | +1.8% | 130,705 | 15.68 |
| 2025-06-30 | 2,014,513 | -27.9% | 581,351 | 3.47 |
| 2025-06-13 | 2,793,266 | -5.1% | 325,038 | 8.59 |
| 2025-05-30 | 2,942,463 | -2.2% | 181,375 | 16.22 |
| 2025-05-15 | 3,008,421 | -7.6% | 183,610 | 16.38 |
| 2025-04-30 | 3,256,620 | -0.4% | 177,323 | 18.37 |
| 2025-04-15 | 3,269,707 | -11.4% | 398,117 | 8.21 |
| 2025-03-31 | 3,689,793 | -1.9% | 247,392 | 14.91 |
| 2025-03-14 | 3,761,654 | +1.0% | 630,583 | 5.97 |
| 2025-02-28 | 3,724,631 | -6.5% | 216,318 | 17.22 |
| 2025-02-14 | 3,984,030 | -1.6% | 269,097 | 14.81 |
| 2025-01-31 | 4,048,269 | -0.1% | 210,528 | 19.23 |
| 2025-01-15 | 4,054,178 | +2.0% | 238,491 | 17.00 |
| 2024-12-31 | 3,973,621 | -2.4% | 273,023 | 14.55 |
| 2024-12-13 | 4,071,061 | -0.1% | 362,074 | 11.24 |
| 2024-11-29 | 4,076,970 | -12.5% | 303,755 | 13.42 |
| 2024-11-15 | 4,661,129 | +1.0% | 602,853 | 7.73 |
| 2024-10-31 | 4,613,842 | -13.8% | 2,228,894 | 2.07 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ANRO volume is 66.8%, up 20.7 points over the last five sessions. Over the last 30 readings it ranged from 42.5% (27 October 2026) to 87.9% (20 October 2026). The latest reading is in line with the 30-session average of 68.8%, on 224K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 150K | 224K | 66.8% | 58 |
| 2026-10-30 | 157K | 210K | 74.9% | 0 |
| 2026-10-29 | 112K | 156K | 71.9% | 0 |
| 2026-10-28 | 80K | 120K | 66.2% | 0 |
| 2026-10-27 | 90K | 211K | 42.5% | 0 |
| 2026-10-26 | 95K | 206K | 46.1% | 0 |
| 2026-10-23 | 125K | 148K | 84.3% | 81 |
| 2026-10-22 | 131K | 237K | 55.4% | 61 |
| 2026-10-21 | 191K | 261K | 73.2% | 1 |
| 2026-10-20 | 270K | 307K | 87.9% | 0 |
| 2026-10-19 | 228K | 292K | 78.1% | 0 |
| 2026-10-16 | 206K | 234K | 87.8% | 0 |
| 2026-10-15 | 159K | 213K | 74.8% | 0 |
| 2026-10-14 | 440K | 845K | 52.1% | 0 |
| 2026-10-13 | 207K | 278K | 74.6% | 5,896 |
| 2026-10-12 | 132K | 168K | 78.9% | 0 |
| 2026-10-09 | 181K | 363K | 50.0% | 0 |
| 2026-10-08 | 105K | 151K | 69.4% | 0 |
| 2026-10-07 | 114K | 138K | 82.5% | 0 |
| 2026-10-06 | 183K | 218K | 83.9% | 0 |
| 2026-10-05 | 159K | 183K | 86.7% | 0 |
| 2026-10-02 | 162K | 204K | 79.3% | 0 |
| 2026-10-01 | 120K | 229K | 52.2% | 0 |
| 2026-09-30 | 128K | 174K | 73.5% | 0 |
| 2026-09-29 | 135K | 212K | 63.4% | 0 |
| 2026-09-28 | 137K | 240K | 57.0% | 0 |
| 2026-09-25 | 93K | 117K | 79.6% | 0 |
| 2026-09-24 | 154K | 256K | 60.2% | 832 |
| 2026-09-23 | 123K | 264K | 46.6% | 2,717 |
| 2026-09-22 | 83K | 129K | 64.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in ANRO is 48 shares, down 538 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (22 June 2026) to 27,992 shares (28 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 48 | $22.09 | $1K |
| 2026-10-02 | 586 | $25.31 | $15K |
| 2026-10-01 | 511 | $25.53 | $13K |
| 2026-09-15 | 128 | $31.68 | $4K |
| 2026-09-14 | 581 | $32.00 | $19K |
| 2026-09-08 | 568 | $35.55 | $20K |
| 2026-08-24 | 3,994 | $34.28 | $137K |
| 2026-08-20 | 100 | $34.89 | $3K |
| 2026-08-18 | 851 | $33.60 | $29K |
| 2026-08-11 | 1,630 | $28.29 | $46K |
| 2026-08-07 | 2,193 | $28.47 | $62K |
| 2026-08-06 | 1,563 | $28.03 | $44K |
| 2026-08-04 | 1,053 | $27.27 | $29K |
| 2026-07-28 | 27,992 | $27.87 | $780K |
| 2026-07-27 | 1,152 | $26.78 | $31K |
| 2026-07-24 | 947 | $26.85 | $25K |
| 2026-07-22 | 2,525 | $27.07 | $68K |
| 2026-07-20 | 7,164 | $27.54 | $197K |
| 2026-07-17 | 2,054 | $27.33 | $56K |
| 2026-07-16 | 2,772 | $27.82 | $77K |
| 2026-07-08 | 3,574 | $25.70 | $92K |
| 2026-07-02 | 650 | $24.94 | $16K |
| 2026-06-29 | 1,523 | $27.04 | $41K |
| 2026-06-26 | 36 | $25.30 | $911 |
| 2026-06-25 | 41 | $24.91 | $1K |
| 2026-06-24 | 857 | $24.44 | $21K |
| 2026-06-23 | 13,843 | $22.93 | $317K |
| 2026-06-22 | 2 | $22.74 | $45 |
| 2026-06-18 | 30 | $21.79 | $654 |
| 2026-06-17 | 2,417 | $21.00 | $51K |
Insider trades
SEC Form 4, newest first. JSONInsiders at ANRO reported 3 open-market sells worth $3.6M in the last 90 days and no open-market buys. Latest filing: Smith Nicholas Conrad (PRESIDENT AND CFO) on 2026-10-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Smith Nicholas Conrad | PRESIDENT AND CFO | Exercise or conversion | 55K | $2.32 | $128K | 79K |
| 2026-09-30 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sell | 886 | $26.87 | $24K | 24K |
| 2026-09-30 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sell | 23K | $25.78 | $597K | 25K |
| 2026-09-30 | Smith Nicholas Conrad | PRESIDENT AND CFO | Exercise or conversion | 24K | $2.35 | $57K | 48K |
| 2026-09-29 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sell | 111K | $26.58 | $2.9M | 24K |
| 2026-09-29 | Smith Nicholas Conrad | PRESIDENT AND CFO | Exercise or conversion | 54K | $2.35 | $128K | 135K |
| 2026-09-29 | Smith Nicholas Conrad | PRESIDENT AND CFO | Exercise or conversion | 56K | $2.35 | $133K | 81K |
| 2026-05-14 | Etkin Amit | PRESIDENT AND CEO | Gift | 400K | $0.00 | $0 | 834K |
| 2026-03-01 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Tax withholding | 3K | $19.69 | $55K | 24K |
| 2026-03-01 | Etkin Amit | PRESIDENT AND CEO | Tax withholding | 6K | $19.69 | $123K | 1.2M |
| 2024-07-10 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 3K | $13.22 | $39K | 40K |
| 2024-07-09 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 1K | $13.15 | $18K | 37K |
| 2024-07-09 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 11K | $12.53 | $134K | 36K |
| 2024-03-28 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 5K | $16.56 | $75K | 27K |
| 2024-03-28 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 2K | $15.80 | $25K | 22K |
| 2024-03-01 | Etkin Amit | PRESIDENT AND CEO | Grant | 35K | $0.00 | $0 | 1.2M |
| 2024-03-01 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Grant | 19K | $0.00 | $0 | 21K |
| 2024-02-06 | Chen Po Yu (Jeff) | Director | Conversion | 39K | price not stated in the filing | not stated | 39K |
| 2024-02-06 | Chen Po Yu (Jeff) | Director | Conversion | 8K | price not stated in the filing | not stated | 48K |
| 2024-02-06 | Etkin Amit | PRESIDENT AND CEO | Conversion | 12K | price not stated in the filing | not stated | 1.2M |
| 2024-02-06 | Etkin Amit | PRESIDENT AND CEO | Buy | 3K | $16.00 | $50K | 1.2M |
| 2024-02-06 | Savitz Adam | CHIEF MEDICAL OFFICER | Conversion | 8K | price not stated in the filing | not stated | 8K |
| 2024-02-06 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 17K | $16.00 | $272K | 25K |
| 2024-02-06 | Cox Christopher Nixon | Director | Conversion | 589K | price not stated in the filing | not stated | 589K |
| 2024-02-06 | Cox Christopher Nixon | Director | Conversion | 127K | price not stated in the filing | not stated | 716K |
| 2024-02-06 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 2K | $16.00 | $25K | 2K |
| 2024-02-06 | York Gwill | Director | Conversion | 24K | price not stated in the filing | not stated | 24K |
| 2024-02-06 | Alpha Wave Global, LP | TenPercentOwner | Conversion | 2.0M | price not stated in the filing | not stated | 2.0M |
| 2024-02-06 | Alpha Wave Global, LP | TenPercentOwner | Conversion | 1.1M | price not stated in the filing | not stated | 3.1M |
| 2024-02-06 | Alpha Wave Global, LP | TenPercentOwner | Buy | 600K | $16.00 | $9.6M | 3.7M |
| 2024-02-06 | Apeiron Investment Group Ltd. | Other | Conversion | 252K | price not stated in the filing | not stated | 252K |
| 2024-02-06 | Apeiron Investment Group Ltd. | Other | Conversion | 675K | price not stated in the filing | not stated | 675K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for ANRO worth $3.6M at the prices reported; 1 in the last 90 days worth $3.6M. Latest: NICHOLAS SMITH filed on 2026-09-29 to sell 134,886 shares ($3.6M) from 2026-09-29.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-29 | NICHOLAS SMITHOfficer | 135K | $3.6M | 0.344% | 2026-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON14 holders report 5% or more of ANRO in their latest filing, all on Schedule 13G (passive). The largest reported stake is Joseph Edelman at 10.0% of the class (4,176,711 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-30 | 13G | Vanguard Capital Managementinvestment adviser | 2.0M | 5.0% | 2026-09-30 |
| 2026-08-14 | 13G/Ano. 2 | Joseph Edelmanindividual | 4.2M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | Perceptive Life Sciences Master Fund, Ltd.corporation | 4.2M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | Perceptive Advisors LLCinvestment adviser | 4.2M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Sirenia Capital Management LPinvestment adviser, partnership | 2.2M | 6.2% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Alex Silversteinparent holding company, individual | 2.2M | 6.2% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | Ryan Wilderparent holding company, individual | 785K | 2.2% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | Vestal Point Capital, LPinvestment adviser, partnership | 785K | 2.2% | 2026-06-30 |
| 2026-07-27 | 13G | BlackRock, Inc.parent holding company | 2.1M | 6.0% | 2026-06-30 |
| 2026-07-20 | 13G | Oleg Nodelmanparent holding company, individual | 2.2M | 5.8% | 2026-07-13 |
| 2026-07-20 | 13G | EcoR1 Capital, LLCinvestment adviser, other entity | 2.2M | 5.8% | 2026-07-13 |
| 2026-07-20 | 13G | EcoR1 Capital Fund Qualified, L.P.partnership | 2.1M | 5.3% | 2026-07-13 |
| 2026-05-15 | 13G/Ano. 2 | Commodore Capital LPinvestment adviser, partnership | 3.6M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Michael Kramarzparent holding company, individual | 3.6M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Robert Egen Atkinsonparent holding company, individual | 3.6M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Commodore Capital Master LPpartnership | 3.6M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 4 | Steven A. Cohenindividual | 1.2M | 3.7% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 4 | Point72 Biotech Private Investments, LLCother entity | 668K | 2.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 4 | Differentiated Ventures Investments, LLCother entity | 668K | 2.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 4 | 72 Investment Holdings, LLCother entity | 668K | 2.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 4 | Point72 Asset Management, L.P.partnership | 503K | 1.6% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 4 | Point72 Capital Advisors, Inc.corporation | 503K | 1.6% | 2026-03-31 |
| 2026-02-18 | 13G/Ano. 3 | Steven Boydparent holding company, individual | 1.5M | 4.9% | 2025-12-31 |
| 2026-02-18 | 13G/Ano. 3 | Armistice Capital, LLCinvestment adviser, other entity | 1.5M | 4.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Anup Aroraindividual, parent holding company | 789K | 2.4% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Parag Shahindividual, parent holding company | 789K | 2.4% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | K2 HealthVentures Equity Trust LLCother entity | 789K | 2.4% | 2025-12-31 |
13F holders
Tracked managers holding ANRO at their latest 13F. JSON4 of the 30 tracked managers held ANRO at their latest 13F, $33.8M in total at quarter-end prices. Millennium Management is the largest at $14.7M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 558K | $14.7M | 0.01% | -264K |
| Point72 Asset Management | 2026-06-30 | 503K | $13.3M | 0.01% | -137 |
| Two Sigma Investments | 2026-06-30 | 147K | $3.9M | 0.00% | -69K |
| Renaissance Technologies | 2026-06-30 | 71K | $1.9M | 0.00% | -32K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Alto Neuroscience in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Alto Neuroscience (ANRO), SEC CIK 1999480, listed on NYSE. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-29.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1999480Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of ANRO is sold short?
What is ANRO's daily short volume?
Does ANRO have fails to deliver?
Are ANRO insiders buying or selling?
Have ANRO insiders filed to sell?
Who owns 5% or more of ANRO?
Which tracked 13F managers own ANRO?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.